In House Warrior: How Companies Can Reduce Risk With Political Disclosure & Accountability With Bruce Freed
Listen on: Spotify, Apple Podcasts, or Google Podcasts!
Mind The Gap
In the USA, political spending and corporate lobbying are well-established as legitimate business activities that give companies the means to have their interest heard by politicians and governments. At the same time, it is an area that – when not managed appropriately – can expose these companies to heightened business, reputational and legal risks.
Follow The Money
US firms face heightened scrutiny of their political spending. Issuers will be thrust further into the political divide heightened from a resolution calling on them to require and disclose reports from trade associations and political action committees they fund detailing exactly where their money goes.
On anniversary of the Capitol attack, companies face new pressures to disclose political spending
Shareholders, consumer groups and lawmakers seeking more details, better oversight of corporate political outlays…
Companies Face Proxy Heat on Political Spending After Dobbs
Shareholder proposals targeting political spending are poised to ramp up in this year’s proxy season, pressing companies to unveil if their sometimes tightly-guarded stances on issues line up with their donations.
A Deeper Dive — On the Sidelines or Taking Sides: Corporations, Elections, Social Responsibility, and Long-Term Impacts on Corporate Governance
The American Bar Association released on Dec. 19, 2022, a video filmed at last September’s Business Law Section Annual Meeting.
Big Business courted big controversies in the 2022 midterm elections. Were the returns on their political donations worth the risks?
In Pennsylvania’s crucial elections this month, Outback Steakhouse’s attempt to back a pro-business candidate went over like a week-old Bloomin’ Onion.
Political Spending Transparency from Russell 1000 Companies? Not So Much
A number of companies, highly sensitized to any misalignment between their political contributions and their public statements, determined to suspend or discontinue some or all of their political donations
Agenda: Investors Keep Up the Pressure on Political Disclosure
Spending misalignment is raising investors’ ire.
STAT+: Amid concerns over U.S. democracy, pharma financed committees that support election deniers
Some candidates continue to deny the results of the 2020 presidential elections…